Menlo Ventures Management, L.P.

MENLO PARK, CA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$240.6M2026 Q3
Positions5
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.100.0%

Menlo Ventures Management, L.P. reported 5 positions worth $240.6M as of September 30, 2026 (13F filed November 6, 2026). Largest holding: CHYM (93.5%).

5 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 CHYMChime Financial$224.8M93.46%8,439,328——+28.7%
▸ 2 SPCXSpace Exploration Technologies$13.8M5.74%91,515——-8.9%
▸ 3 SCTXScribe Therapeutics$1.8M0.75%97,690——-13.3%
▸ 4 BRZEBraze$115.8K0.05%4,614——+85.5%
▸ 5 SNTISenti Biosciences$11.2K0.01%35,737——-55.1%

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does Menlo Ventures Management, L.P. hold as of Q3 2026?

Menlo Ventures Management, L.P. reported 5 positions worth $240.6M in its Q3 2026 13F filing. Largest positions: CHYM (93.5%), SPCX (5.7%), SCTX (0.7%), BRZE (0.0%) and SNTI (0.0%).

What did Menlo Ventures Management, L.P. buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Menlo Ventures Management, L.P. sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.